JAK2 and neoplasm: As shown in Fig. 5f, LOH for JAK1 was detected in 25% (15 of 59) and for JAK2 in 76% (45 of 59) of the cell lines suggesting a high risk of resistance development in the course of an effective anti-tumour T-cell response.